Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings.

Journal of the International Neuropsychological Society : JINS - 1 Sept 2010

Cherner Mariana, Bousman Chad, Everall Ian, Barron Daniel, Letendre Scott, Vaida Florin, Atkinson J Hampton, Heaton Robert, Grant Igor

Abstract excerpt

While neuropsychological deficits are evident among methamphetamine (meth) addicts, they are often unrelated to meth exposure parameters such as lifetime consumption and length of abstinence. The notion that some meth users develop neuropsychological impairments while others with similar drug exp...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amphetamine-Related Disorders
Share to Cognition Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2D6

Share to Genotype

Share to Memory

Share to Methamphetamine

Share to Neuropsychological Tests

Share to Statistics, Nonparametric

Source

Open in PubMed Open full text

Identifiers

PMID: 20727252
DOI: 10.1017/S1355617710000779
PMCID: PMC3543816

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20727252-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings.PMID 20727252Read ↗

CYP2D6 genotype may moderate measures of brain structure in methamphetamine users.Semantic proximity Read ↗

Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence.Semantic proximity Read ↗

Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.Semantic proximity Read ↗

Prospective cytochrome P450 phenotyping for neuroleptic treatment in dementia.Semantic proximity Read ↗

The influence of genetic and environmental factors among MDMA users in cognitive performance.Semantic proximity Read ↗

Pharmacogenomics as an aspect of molecular autopsy for forensic pathology/toxicology: does genotyping CYP 2D6 serve as an adjunct for certifying methadone toxicity?Semantic proximity Read ↗

Association between cytochrome P450 2D6 polymorphisms and body fluid methamphetamine concentrations in Japanese forensic autopsy cases.Semantic proximity Read ↗

Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults - results from the ActiFE study.Semantic proximity Read ↗

Studies on Para-Methoxymethamphetamine (PMMA) Metabolite Pattern and Influence of CYP2D6 Genetics in Human Liver Microsomes and Authentic Samples from Fatal PMMA Intoxications.Semantic proximity Read ↗

Metabolism of almitrine in extensive and poor metabolisers of debrisoquine/sparteine.Semantic proximity Read ↗

Effects of genetic variability of CYP2D6 on neural substrates of sustained attention during on-task activity.Semantic proximity Read ↗

Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.